Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: Am Econ J Econ Policy. 2018 Nov;10(4):1–35. doi: 10.1257/pol.20170082

Table 4:

Relationship Between OxyContin Misuse and Changes in Opioid Death Rates

Outcome: Overdose Deaths per 100,000
(1) (2) (3) (4) (5) (6)
A. Total Opioid Deaths per 100,000 (T40.2-T40.4)
Initial OxyContin (3 Year Effect) −1.135 (1.921) −0.266 (1.765) −0.420 (1.698) 0.789 (1.836) 0.089 (0.219) 0.146 (0.253)
Initial Pain Reliever (3 Year Effect) −0.554 (0.358) −0.067 (0.052)
Mean of Dep. Variable (2008–09): 5.192
B. Natural Opioid Deaths per 100,000 (T40.2)
Initial OxyContin (3 Year Effect) −2.699 (1.888) −2.243 (1.810) −2.388 (1.700) −1.700 (1.821) −0.652** (0.293) −0.629** (0.312)
Initial Pain Reliever (3 Year Effect) −0.304 (0.342) −0.023 (0.067)
Mean of Dep. Variable (2008–09): 3.233
C. Natural Opioid-Only Deaths per 100,000 (T40.2, but not also T40.1, T40.3, or T40.4)
Initial OxyContin (3 Year Effect) −3.015* (1.671) −2.636* (1.555) −2.742* (1.392) −2.337 (1.423) −0.794*** (0.305) −0.807*** (0.309)
Initial Pain Reliever (3 Year Effect) −0.167 (0.275) 0.016 (0.063)
Mean of Dep. Variable (2008–09): 2.593

State and Time-Varying Covariates No Yes Yes Yes Yes Yes
Policy Variables No No Yes Yes Yes Yes
Estimator OLS OLS OLS OLS Poisson Poisson

Notes: Standard errors in parentheses adjusted for clustering at the state-level. State fixed effects and year fixed effects included in all specifications. Each model also includes a linear trend interacted with initial nonmedical OxyContin misuse as well as a post-2011 indicator interacted with initial nonmedical OxyContin misuse. Finally, a separate post-2011 linear trend interacted with initial nonmedical OxyContin misuse is also included. We report the 3 year post-2011 effect of the initial OxyContin variable. Regressions are weighted by population. Years 2008–2013 are used.

***

Significant at the 1% level

**

Significant at the 5% level

*

Significant at the 10% level.